Table 6 Treatment-related SAEs during RENEW annual follow-up phase
SAE | Annual follow-up phase (n = 250) | ||
|---|---|---|---|
| Â | Number of treatment-related events | ||
| Â | Possible | Probable | Total |
Decreased ejection fraction | 0 | 2 | 2 |
Acute myeloid leukemia | 0 | 1 | 1 |
Pneumonia | 0 | 1 | 1 |
Anorexia | 1 | 0 | 1 |
Cardiomyopathy | 1 | 0 | 1 |
Tachycardia | 1 | 0 | 1 |
Chronic myeloid leukemia | 1 | 0 | 1 |
Endometrial cancer | 1 | 0 | 1 |
Carotid artery occlusion | 1 | 0 | 1 |
Cerebrovascular accident | 1 | 0 | 1 |
Dyspnea | 1 | 0 | 1 |